Press Release - UNICEF has signed an agreement that secures supply of the MVA-BN mpox vaccine at the lowest market price and ensures access to the vaccine for 77 low- and lower-middle-income countries ...

In an emulated target trial, a single dose of modified vaccinia Ankara-Bavarian Nordic vaccine was moderately effective in ...

The rate of mpox infection in the vaccinated group was 0.09 for every 1,000 person-days as compared to 0.20 in the ...

"This study reinforces the benefit in vaccinating against mpox with MVA-BN and reaffirms that a single dose provides at least ...

On September 13, 2024, the World Health Organization (WHO) announced that it added the first vaccine against monkeypox (mpox) to its ...

The African health agency says that Rwanda has started a vaccination campaign against mpox with 1,000 doses it obtained from ...

The World Health Organization (WHO) has authorized the MVA-BN vaccine as the first vaccine against mpox to be added to its ...

The World Health Organization Friday approved MVA-BN as the first mpox vaccine added to its pre-qualification list.

(RTTNews) - Bavarian Nordic A/S (BAVA) Thursday said that the European Commission has adopted the Committee for Medicinal Products for Human Use (CHMP) recommendation for the approval of a type II ...

In a recent study, one dose of modified vaccinia Ankara-Bavarian Nordic vaccine had estimated vaccine effectiveness of 58%. HealthDay News — One dose of modified vaccinia Ankara-Bavarian Nordic ...

Bavarian Nordic receives WHO prequalification for IMVANEX as the first vaccine against mpox, accelerating access in African ...

One dose of modified vaccinia Ankara-Bavarian Nordic vaccine is moderately effective against mpox infection in at-risk communities.